Literature DB >> 8889650

Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.

N R Puttagunta1, W A Gibby, V L Puttagunta.   

Abstract

RATIONALE AND
OBJECTIVES: The relative stability and selectivity of magnetic resonance (MR) imaging contrast agents were compared with in vitro transmetallation and ligand competition reactions.
MATERIALS AND METHODS: A gadolinium (Gd)-DTPA-BIGA, Gd-DTPA-BMA, Gd-DTPA, or Gd-HP-DO3A solution was mixed with an equimolar solution of zinc (Zn) citrate in 1:1 volume ratio at pH 7.4 in a transmetallation assay. In a ligand competition reaction, a DTPA or EDTA solution was mixed with an equimolar solution of Gd-DTPA-BIGA, Gd-DTPA-BMA, or Gd-HP-DO3A. The progress of the reactions was followed with high-performance liquid chromatography (HPLC) using fluorescence detection.
RESULTS: In the transmetallation study with Zn citrate, the order of kinetic stability is Gd-HP-DO3A > Gd-DTPA > Gd-DTPA-BIGA > Gd-DTPA-BMA. The order of stability in the ligand competition reaction is Gd-HP-DO3A > Gd-DTPA-BIGA > Gd-DTPA-BMA.
CONCLUSIONS: Transmetallation kinetics shows major differences among currently used MR imaging contrast media. Equilibrium thermodynamic constants and selectivity constants calculated therefrom do not explain the relative kinetic stability and metal selectivity of MR contrast media in the presence of competing metal ions and ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889650     DOI: 10.1097/00004424-199610000-00003

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  9 in total

1.  Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats.

Authors:  Xueming Wu; Yuda Zong; Zhen Ye; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2010-07       Impact factor: 4.200

2.  Lanthanides Release and Partitioning in Municipal Wastewater Effluents.

Authors:  Patrice Turcotte; Shirley Anne Smyth; François Gagné; Christian Gagnon
Journal:  Toxics       Date:  2022-05-17

3.  [Nephrogenic systemic fibrosis].

Authors:  W Samtleben
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

Review 4.  Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.

Authors:  Hale Ersoy; Frank J Rybicki
Journal:  J Magn Reson Imaging       Date:  2007-11       Impact factor: 4.813

5.  Safety of contrast-enhanced MR angiography employing gadobutrol 1.0 M as contrast material.

Authors:  Jörn O Balzer; Christian Loewe; Kirsten Davis; Mathias Goyen; Tim Leiner; James F M Meaney; Christiane Pöckler-Schöniger; Gernot Schulte-Altedorneburg; Bernd Tombach; Rolf Vosshenrich; Robin Wegener
Journal:  Eur Radiol       Date:  2002-12-03       Impact factor: 5.315

Review 6.  [Nephrogenic systemic fibrosis (NSF)--implications for radiology].

Authors:  H J Michaely; H S Thomsen; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

7.  Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents.

Authors:  Hubertus Pietsch; Philipp Lengsfeld; Gregor Jost; Thomas Frenzel; Joachim Hütter; Martin A Sieber
Journal:  Eur Radiol       Date:  2009-01-24       Impact factor: 5.315

8.  Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac.

Authors:  Jihong Wang; Travis Salzillo; Yongying Jiang; Yuri Mackeyev; Clifton David Fuller; Caroline Chung; Seungtaek Choi; Neil Hughes; Yao Ding; Jinzhong Yang; Sastry Vedam; Sunil Krishnan
Journal:  Radiother Oncol       Date:  2021-06-03       Impact factor: 6.901

Review 9.  Gadolinium and nephrogenic systemic fibrosis: time to tighten practice.

Authors:  Iosif A Mendichovszky; Stephen D Marks; Clare M Simcock; Oystein E Olsen
Journal:  Pediatr Radiol       Date:  2007-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.